OS Therapies Announces FDA PDUFA Waiver & EMA Grants Union Marketing Authorisation EligibilityDecember 05, 2025 8:01 AM EST | Source: OS TherapiesU.S. FDA grants waiver of application fee for BLA Filing of OST-HER2Scheduled pre-Marketing Authorisation Application meeting with United Kingdom's Medicines and Healthcare products Regulatory Agency on December 8, 2025Scheduled Type C Meeting with United States Food & Drug Administration on December 11, 2025New York, New York--(Newsfile Corp. - Dece ...